BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 20466784)

  • 1. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
    Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes.
    Favaro E; Carpanetto A; Lamorte S; Fusco A; Caorsi C; Deregibus MC; Bruno S; Amoroso A; Giovarelli M; Porta M; Perin PC; Tetta C; Camussi G; Zanone MM
    Diabetologia; 2014 Aug; 57(8):1664-73. PubMed ID: 24838680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of a broad repertoire of GAD65-specific T-cells in type 1 diabetes patients with graft dysfunction after allogeneic islet transplantation.
    Chujo D; Foucat E; Takita M; Itoh T; Sugimoto K; Shimoda M; Yagi K; Yamagishi M; Tamura Y; Yu L; Naziruddin B; Levy MF; Ueno H; Matsumoto S
    Cell Transplant; 2012; 21(12):2783-95. PubMed ID: 22963904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory properties of colonic mesenchymal stem cells.
    Hu J; Zhang X; Zhou L; Zhang Y
    Immunol Lett; 2013; 156(1-2):23-9. PubMed ID: 24060593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of GAD65 reactive T cells in some Chinese subjects initially diagnosed as with idiopathic type 1 diabetes].
    Zhang Y; Zhou ZG; Yang L; Zhou HF; Lin J; Sun Y; Huang G
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1102-5. PubMed ID: 17672990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.
    Faresjö MK; Vaarala O; Thuswaldner S; Ilonen J; Hinkkanen A; Ludvigsson J
    Diabetes Metab Res Rev; 2006; 22(6):462-70. PubMed ID: 16572494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.
    Hermankova B; Zajicova A; Javorkova E; Chudickova M; Trosan P; Hajkova M; Krulova M; Holan V
    Immunobiology; 2016 Feb; 221(2):129-36. PubMed ID: 26416211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients.
    Favaro E; Carpanetto A; Caorsi C; Giovarelli M; Angelini C; Cavallo-Perin P; Tetta C; Camussi G; Zanone MM
    Diabetologia; 2016 Feb; 59(2):325-33. PubMed ID: 26592240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes.
    Boettler T; Pagni PP; Jaffe R; Cheng Y; Zerhouni P; von Herrath M
    J Autoimmun; 2013 Aug; 44():40-8. PubMed ID: 23770292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.
    Hegyi B; Kudlik G; Monostori E; Uher F
    Biochem Biophys Res Commun; 2012 Mar; 419(2):215-20. PubMed ID: 22333568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.
    Conforti A; Scarsella M; Starc N; Giorda E; Biagini S; Proia A; Carsetti R; Locatelli F; Bernardo ME
    Stem Cells Dev; 2014 Nov; 23(21):2591-9. PubMed ID: 24937591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis.
    Hsu WT; Lin CH; Chiang BL; Jui HY; Wu KK; Lee CM
    J Immunol; 2013 Mar; 190(5):2372-80. PubMed ID: 23359497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of effects between IL-2 and IL-7 on glutamic acid decarboxylase 65 reactive T cell responses in patients with Type 1 diabetes].
    Yuan J; Cui Q; Tang W; Chao C; Zhou Z; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1257-1262. PubMed ID: 29187651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
    Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.